ABOUT GCC REGULATORY AFFAIRS PHARMA SUMMIT
GCC Regulatory Affairs Pharma Summit is an annual event that provides platform for pharmaceutical regulatory experts and industry professionals in the GCC region to share insights and discuss about the latest updates in the pharmaceutical regulations.
This Summit is one of the first and strategic meeting place in the GCC region for local and international pharmaceutical and medical industry professionals to meet and discuss on topics related to all aspects of regulatory affairs, legal and compliance.
Post-Event Reports
Where
Movenpick Grand Al Bustan – Dubai, UAE
When
17-18 February 2025
SPEAKERS
50+ Speakers
SEATS
350+ Seats
Benefits of Attending
Meet Top Decision Makers
More than 350+ porfessionals attend from the pharmaceutical and healthcare industry to learn and share knowledge
Get Proactive & Productive
A Two-day summit filled the exchange of strategized ideas analysis & exclusive new regulatory updates
Informative-Leading Platform
Interactive formats: industry leaders’ debates, interviews, discussions, analyses, Q&A, round tables & more.
Speakers 2025
The GCC Regulatory Affairs Pharma Summit 2025 gathers experts to explore regulatory updates, compliance, and pharma innovations in the Gulf.
Dr. Hanady Yousef Shourrab
Ph. Muna Al Saidi
Ph. Muna Al Saidi stands as a dedicated professional at the forefront of healthcare administration, currently holding the esteemed position of Section Head in the Registration Section of Human Medicine at the Ministry of Health, Oman. With a passion for ensuring the seamless operation of medical registration processes, Muna Al Saidi has become a respected figure in the healthcare sector of Oman.
Known for her strategic vision and meticulous attention to detail, Muna Al Saidi has played a pivotal role in streamlining registration procedures within the Ministry of Health. Her commitment to excellence has not only earned her the trust of her colleagues but has also contributed significantly to the overall efficiency of the healthcare system in Oman.
As a seasoned leader, Muna Al Saidi brings a wealth of experience to her role, coupled with a deep understanding of the complexities involved in managing the registration of human medicine. Her dedication to advancing healthcare services reflects a commitment to enhancing the well-being of the Omani population.
Ph. Noha Allawati
- Msc – Supply Chain & Logistic Management (Glasgow, Strathclyde University, UK)
- Master of Pharmacy (M-Pharm) (Liverpool John Moores University, UK)
- Diploma – Pharmacy (Institute of Pharmacy, Oman)
- Positions
- Regulatory Staff – Drug Control Department – Variation Section (November 2022 onwards)
- Director of Medical Store (Laboratory Materials & Supplies)- Directorate General of Medical Supply )2021-2022 )
- Head of Department of Receiving Section – Directorate General of Medical Supply )2019-2021)
- Pharmacist in Quality Department – Directorate General of Medical Supply )2018-2019)
- Head Of Department of Injection Section – Directorate General of Medical Supply )2017- 2018)
- Acting Head of Injection Section – Directorate General of Medical Supply )2016- 2017)
- Acting Head of Syrup Section – Directorate General of Medical Supply )2015-2016)
- Pharmacist in Directorate General of Medical Supply (2011- 2015)
- Pharmacy In charge – Wilayat Bousher (2008-2011)
- Pharmacist in Al khuwair Health Center (2003 – 2008)
- Publications
- Lean Practitioners project (Accuracy in Quantifying the annual requirement of lab disposable items ( February 2022 till June 2022)
- Literature review on statins & rhabdomyolysis published in LENS magazine March 2011 Oman
- Acne (Is isoisotretinion the solution?) – The Reflection (Wilayat Muscat Health services Newsletter) on January 2006
Dr. Anees Puthan Veettil
Dr. Anees Puthan Veettil is a strategic leader with over 20 years of experience in Drug Development, specializing in pharmaceutical studies and clinical trials. He holds a Pharmacy Post-Graduation in Pharmacology from Dr. MGR Medical University, India, and a specialization in Clinical Research & Regulatory Affairs from York College, Canada.
Dr. Veettil currently leads the Evaluation Unit of Pharmaceutical Studies at the Ministry of Health and Prevention in the UAE. He has expertise in Pharmaceutical Studies Evaluation, Clinical Operations, Regulatory Affairs, Quality Assurance, R&D, GMP Audits, and Project Management, with experience working with global pharmaceutical companies like GlaxoSmithKline.
In addition, he is a visiting faculty member at various research and pharmacy institutes and has trained doctors and ethics committees on clinical research.
Dr. Afrah Husam Kakai
Education and experience:
– pharmacist, graduated from Hawler medical university (HMU)
College of pharmacy (2014,2015)
-over 8 years experience in regulatory affairs and registration regulations for pharmaceutical sites and products, ensuring:
1.the compliance with national and international regulations, fostering adherence to healthcare standards.
2.Provided expert guidance to pharmaceutical companies, enhancing their understanding of compliance requirements.
Ph. Hanan Salim Al-Habsi
Hanan Salim is a Senior Specialist Pharmacist with over 15 years of experience in hospital pharmacy, currently serving at Sultan Qaboos University Hospital in Oman. In her role, Hanan excels in supervising clinical pharmacists and providing expert guidance on medication selection and management. She is passionate about training pharmacy and medical students in clinical practices, as well as in medication prescribing and management.
Hanan holds a Master of Science in Clinical Pharmacology from the University of Aberdeen, where her studies included clinical research, drug discovery, and pharmacovigilance. With a strong background in both clinical and research settings, she is dedicated to advancing pharmaceutical care, supporting clinical trials, and ensuring compliance with industry standards. Her extensive experience and leadership significantly enhance patient care and medication safety within her institution.
Dr. Mona Al Moussli
Dr. Mona Al Moussli is a trailblazer in the field of pharmaceutical and medical device regulatory affairs in the Middle East. With over twenty years of experience, she has firmly established herself as a seasoned professional renowned for her unparalleled expertise in navigating the intricacies of healthcare regulations.
Throughout her career, Dr. Al Moussli has demonstrated an unwavering dedication to upholding the highest standards of ethics and compliance within the industry. In 2013, she co-founded PRA Consultancy, a firm that has since become synonymous with regulatory excellence in the region.
Her impact transcends traditional boardroom boundaries as she actively works to shape the future of healthcare regulation through education and advocacy. Notably, Dr. Al Moussli played a pivotal role in the inception of the GCC Regulatory Affairs (RA) Course, a pioneering certification program designed to nurture the next generation of industry experts.
Fueled by her passion for advancing health and safety standards, Dr. Al Moussli has spearheaded numerous initiatives, including the renowned GCC Regulatory Affairs Pharma Summit and other significant gatherings focused on pharmaceutical-related regulations in the region.
Dr. Al Moussli’s commitment to advancing regulatory standards transcends borders, as evidenced by her initiation of the AFRI Summit. This crucial platform facilitates discussions on pharmaceutical and medical device regulations in Africa, fostering knowledge sharing and collaboration among stakeholders to improve healthcare outcomes across the continent.
Beyond her professional achievements, Dr. Al Moussli remains actively involved in community engagement, serving as an advisory board member at Dubai Pharmacy College and lending her expertise to the Women’s Business Council at the Dubai Chamber of Commerce. In recognition of her outstanding contributions, Dr. Mona Al Moussli was elected as a board member of the Emirates Medical Association – Pharmacy chapter for consecutive terms in 2021 and 2022.
Dr. Ramzi Sarraj
With a PhD in Pharmacy, an Executive MBA from Paris Dauphine, and an International Certificate in Corporate Finance from HEC Paris, Dr. Sarraj brings a unique blend of expertise in regulatory affairs, development, and strategic management.
Currently serving as the Director of Regulatory Affairs, and Pharmacovigilance at SAIPH Group in the Middle East and Africa, he has a proven track record of driving successful projects, partnerships, and regulatory strategies across diverse markets.
Get Involved
Partner With Us
Showcase yourself as an established provider in the pharmaceutical industry & highlight your organization amongst industry professionals
Become A Speaker
If you are expert in the Pharma Regulatory Affairs field with a great story to tell then let us know and join the speakers panel
Attend
Learn about the new and updated GCC regulations in the pharma industry by attending the GCC Regulatory Affairs Pharma Summit in Dubai, UAE